Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing ...

Bristol Myers Squibb today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for iberdomide combined with standard treatment (daratumumab + ...

When the pancreas stops producing insulin, glucose doesn't enter our cells. Instead, it accumulates in the bloodstream. In ...

Two experts share the Aussie names with big catalysts on the horizon.

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

As I look back on the past year, it is clear that 2025 was one of the most significant and value-creating years in Halozyme Therapeutics, Inc.'s history. This level of execution has created a clear ...

With labour unions demanding a hike in the minimum EPS-95 pension from Rs 1,000, the debate has once again reached Parliament and the Supreme Court. While the government has acknowledged ...

SamaCare, the leading prior authorization platform for medical benefit drugs, today announced that more than $6.2 billion in specialty medication prior authorizations (PAs) were processed through its ...

Bristol Myers Squibb said the U.S. Food and Drug Administration has granted priority review to its application seeking approval of its iberdomide drug candidate in certain patients with the blood ...

Spanish actor Antonio Banderas has announced that he will financially support the work of renowned bio-chemist Dr Mariano ...

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, rezpegaldesleukin (rezpeg), in atopic dermatitis (AD).

Some bacterial species possess an astonishing ability: They use Earth's magnetic field to orient themselves. To better understand this mechanism, the team led by Argovia-Professor Martino Poggio from ...